ETF · real data, updated daily
XBI · State Street SPDR S&P Biotech ETF
Over the last 15 years (2011-10 to 2026-10), $10,000 invested in XBI with dividends reinvested grew to $78,814, 14.67% a year, with a worst peak-to-trough fall of -56.67%. Past performance doesn't predict future results.
Growth of $10,000 · 2011-10 to 2026-10 · dividends reinvested
How XBI held up in past market crashes
XBI has been through 4 of the market crashes since 2000 in our data. Its deepest price fall was 45.6% in the 2022 bear market, when the S&P 500 fell 25.4%. It took 3.5 years from the bottom to get back to its high. No fund is safe from losses; past falls do not predict future ones.
| Crash | XBI deepest fall | S&P 500 (SPY) | Peak to bottom | Back to peak |
|---|---|---|---|---|
| 2008 financial crisis | -37.6% | -56.5% | Aug 2008 to Mar 2009 | 2.1 years |
| 2018 fourth-quarter selloff | -32.7% | -20.2% | Sep 2018 to Dec 2018 | 12 months |
| 2020 COVID crash | -32.9% | -34.1% | Feb 2020 to Mar 2020 | 2 months |
| 2022 bear market | -45.6% | -25.4% | Jan 2022 to May 2022 | 3.5 years |
Price declines in the fund's listing currency, dividends not included, inside each crash's S&P 500 peak-to-bottom window. See how 50 popular ETFs compare in the crash study.
About XBI
State Street SPDR S&P Biotech ETF is an exchange-traded fund that provides targeted exposure to U.S. biotechnology companies. It seeks to track the S&P Biotechnology Select Industry Index, using an equal-weighted approach that gives relatively balanced representation across the portfolio rather than concentrating heavily in the largest firms.
Fund description from our market-data provider.
Put XBI to the test
Every tool below opens prefilled with XBI: free, no account needed.
Backtest XBI →
Full history, any date range, benchmarks, drawdowns, rolling returns.
Would XBI survive 2008? →
What actually happened to it in the crisis: real drawdown and recovery.
Project it forward →
Monte Carlo simulation of where it could go from here.
Compare XBI vs VTI →
Side by side with the total US market: returns, drawdowns and volatility over their shared history.
Replay $100/mo into XBI →
Animated growth of steady monthly contributions.
Fundamentals →
Holdings-level financials where available.
Educational use only, not investment advice. Results are hypothetical.Read full disclaimer
This tool is for educational and informational purposes only and does not provide financial, investment, tax, legal, or accounting advice. Results are hypothetical and based on historical data and assumptions that may be inaccurate. Past performance does not guarantee future results. Consult a licensed professional before making investment decisions.